Form D · Pharmaceuticals
Aurora Pharmaceutical, LLC
Northfield, MN · CIK 0001486301
Offering snapshot reported May 27, 2015 · SEC filing
- Reported sold
- $2.41M Offering amount: $2.41M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $612K Reported outside-investor minimum
- First sale
- May 18, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 27, 2015 | Initial | $2,412,000 | No comparison | 3 | SEC filing |
| Nov 23, 2011 | Amendment | $5,045,000 | $1,985,000vs Mar 7, 2011 | 42 | SEC filing |
| Mar 7, 2011 | Amendment | $3,060,000 | No comparison | 33 | SEC filing |
| Mar 23, 2010 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-240572
Source: Form D, filed May 27, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael A. Strobel | Director, Executive |
| Mark G. Werner | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1196 S. Highway 3
Northfield, MN, 55057
Northfield, MN, 55057